Literature DB >> 22424218

Redefining clinical trials: the age of personalized medicine.

Gayathri Vaidyanathan.   

Abstract

The triumph of personalized cancer therapeutics in recent years is prompting some oncologists to rethink clinical trial design; other researchers have different priorities for trial reform.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22424218     DOI： 10.1016/j.cell.2012.02.041

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  9 in total

1.  Team Learning for Healthcare Quality Improvement.

Authors:  Narine Manukyan; Margaret J Eppstein; Jeffrey D Horbar
Journal:  IEEE Access       Date:  2013-08-28       Impact factor: 3.367

2.  An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors.

Authors:  Oliver Jonas; Heather M Landry; Jason E Fuller; John T Santini; Jose Baselga; Robert I Tepper; Michael J Cima; Robert Langer
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

3.  Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients.

Authors:  William J Kowalczyk; Jeremiah W Bertz; Landhing M Moran; Karran A Phillips; Udi E Ghitza; David H Epstein; Kenzie L Preston
Journal:  J Addict Med       Date:  2017 Nov/Dec       Impact factor: 3.702

4.  Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.

Authors:  Li-Shiun Chen; Timothy B Baker; Douglas Jorenby; Megan Piper; Nancy Saccone; Eric Johnson; Naomi Breslau; Dorothy Hatsukami; Robert M Carney; Laura J Bierut
Journal:  Drug Alcohol Depend       Date:  2015-06-23       Impact factor: 4.492

Review 5.  Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.

Authors:  Li-Shiun Chen; Laurie Zawertailo; Thomas M Piasecki; Jaakko Kaprio; Marilyn Foreman; Hannah R Elliott; Sean P David; Andrew W Bergen; James W Baurley; Rachel F Tyndale; Timothy B Baker; Laura J Bierut; Nancy L Saccone
Journal:  Nicotine Tob Res       Date:  2018-03-06       Impact factor: 4.244

6.  Metasignatures identify two major subtypes of breast cancer.

Authors:  Q Duan; Y Kou; N R Clark; S Gordonov; A Ma'ayan
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-03-27

7.  Network-based drug discovery by integrating systems biology and computational technologies.

Authors:  Elaine L Leung; Zhi-Wei Cao; Zhi-Hong Jiang; Hua Zhou; Liang Liu
Journal:  Brief Bioinform       Date:  2012-08-09       Impact factor: 11.622

8.  Theranostic barcoded nanoparticles for personalized cancer medicine.

Authors:  Zvi Yaari; Dana da Silva; Assaf Zinger; Evgeniya Goldman; Ashima Kajal; Rafi Tshuva; Efrat Barak; Nitsan Dahan; Dov Hershkovitz; Mor Goldfeder; Janna Shainsky Roitman; Avi Schroeder
Journal:  Nat Commun       Date:  2016-11-10       Impact factor: 14.919

9.  Perspective: Does personalized medicine hold the future for medicine?

Authors:  Akosua Adom Agyeman; Richard Ofori-Asenso
Journal:  J Pharm Bioallied Sci       Date:  2015 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.